New Four-Drug attack on tough gallbladder cancer
NCT ID NCT07310069
Summary
This study is testing a new four-drug combination for people with advanced gallbladder cancer that cannot be removed by surgery. The main goals are to see if the treatment can shrink tumors enough to allow for surgery and to measure how well patients respond. It will involve 44 participants at three centers in China.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GALLBLADDER CANCER UNRESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xinhua hospital
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.